Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2005
12/08/2005US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
12/08/2005US20050272072 Ligand-dependent protein splicing
12/08/2005US20050272069 using tumor-associated genes and encoded gene products in tumor diagnosis
12/08/2005US20050272067 Compositions, splice variants and methods relating to cancer specific genes and proteins
12/08/2005US20050272065 Differential enzymatic fragmentation by whole genome amplification
12/08/2005US20050272064 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control
12/08/2005US20050272058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2005US20050272053 Oligonucleotides labeled with a plurality of fluorophores
12/08/2005US20050272050 Receptor protein for identifying modulators to treat and prevent inflammatory, antherosclerotic and cancer disorders; wound healing agents
12/08/2005US20050272048 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
12/08/2005US20050272045 Anti-Hpr6 agents, to enhance the killing effect of anti-cancer agents in non-sarcoma tumor cells and to teat non-sarcoma tumors
12/08/2005US20050272042 preselecting via computational techniques; high speed hybridization; bioinformatics
12/08/2005US20050272041 isolated polynucleotide encoding Enzymatic proteins for use in food processing, paper making and recycling
12/08/2005US20050272039 Nucleic acid analysis chip and nucleic acid analyzer
12/08/2005US20050272034 Methods of detecting ovarian neoplasia
12/08/2005US20050272030 Nucleic acid constructs for gene expression
12/08/2005US20050271682 Administering the chimeric protein, comprising at least a first and a second polypeptide, wherein the N-terminus of the chimeric protien comprises the first polypeptide, wherein the first polypeptide comprises Borrelia burgdorferi OspC and wherein second polypeptide comprises Borrelia burgdorferi OspA
12/08/2005US20050271681 Isolated FrpB nucleic acid molecule and vaccine
12/08/2005US20050271680 Using immunogenic proteins LigA and LigB from Leptospira in development of effective vaccines and antibodies; detection of pathogenic Leptospira infection in a mammal
12/08/2005US20050271679 Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens
12/08/2005US20050271676 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
12/08/2005US20050271668 Janus family kinases and identification of immune modulators
12/08/2005US20050271663 treating rheumatoid arthritis by using single domain antibody polypeptide construct that binds human TNF- alpha
12/08/2005US20050271659 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
12/08/2005US20050271655 Nogo receptor antagonists
12/08/2005US20050271647 Chimeric pro-caspases and methods of using same
12/08/2005US20050271644 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives
12/08/2005US20050271642 Genetically engineering organisms that produce proteins lethal to larvae of insects nucleotide sequences isolated from Bacillus popilliae encode two adjacent, putative genes; orf1 and cryhime; insecticides, larvicides, pesticides; beetles
12/08/2005US20050271637 BMP-2 estrogen responsive element and methods of using the same
12/08/2005US20050271625 RAAV-neprilysin compositions and methods of use
12/08/2005US20050271618 Methods of reducing aggregation of IL-1ra
12/08/2005US20050271589 For therapy of cancer; for therapy of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors
12/08/2005CA2604243A1 Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
12/08/2005CA2568019A1 Assay for transmissible spongiform encephalopathies
12/08/2005CA2568013A1 Nuclease resistant double-stranded ribonucleic acid
12/08/2005CA2567814A1 Antibodies as t cell receptor mimics, methods of production and uses thereof
12/08/2005CA2567624A1 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
12/08/2005CA2567337A1 Methods for dynamic vector assembly of dna cloning vector plasmids
12/07/2005EP1602729A2 Methods for producing transgenic plants
12/07/2005EP1602725A2 Abasic-nucleotide containing enzymatic nucleic acid
12/07/2005EP1602724A1 Magnetic pigment
12/07/2005EP1602668A1 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/07/2005EP1601970A2 Detection, monitoring and treatment of cancer
12/07/2005EP1601966A2 Methods and compositions for purification of nucleic acid from a host cell
12/07/2005EP1601793A2 Methods for detection of genetic disorders
12/07/2005EP1601789A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
12/07/2005EP1601785A1 Methods for detection of genetic disorders
12/07/2005EP1601779A2 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
12/07/2005EP1601688A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae
12/07/2005EP1601684A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
12/07/2005EP1601682A2 Compositions and methods for diagnosing and treating prostate cancer
12/07/2005EP1601681A2 Oligonucleotide mimetics
12/07/2005EP1601373A2 Intracellular delivery of small molecules proteins and nucleic acids
12/07/2005EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them
12/07/2005EP1601325A2 Antisense oligonucleotides that inhibit expression of hif-1
12/07/2005EP1485500A4 Efficient synthesis of protein-oligonucleotide conjugates
12/07/2005EP1341931A4 Detection of dna damage
12/07/2005EP1222309B1 Human rnase h and oligonucleotide compositions thereof
12/07/2005EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders
12/07/2005EP0871646A4 Dna sequencing by parallel oligonucleotide extensions
12/07/2005EP0738328B1 Composition containing nucleic acids, preparation and uses
12/07/2005EP0724589B1 A method for enhancing neurone survival and agents useful for same
12/07/2005EP0716701B1 Agent comprising serine-threonine kinase for the diagnostic and therapy of tumors
12/07/2005EP0697893B1 Neural thread protein gene expression and detection of alzheimer's disease
12/07/2005CN1704426A Cancer gene and its medical use
12/07/2005CN1704425A Human FL polynucleotide and use of human GM-CSF united gene therewith for treating malignant tumor
12/07/2005CN1230546C Transformation system in field of flamentrous fungel hosts in chrysosporium
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230535C Isolated peptides which form complexes with MHC molecule HLA-C-Clone 10 and uses thereof
12/07/2005CN1230445C Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof
12/07/2005CN1230440C Isolation of nucleic acids
12/06/2005US6973388 Using computers
12/06/2005US6972330 Chemical synthesis of methoxy nucleosides
12/06/2005US6972329 Materials and methods for releasing genetic material
12/06/2005US6972328 can comprise DNA, RNA, PNA, or any combination or chimera thereof
12/06/2005US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
12/06/2005US6972197 Transforming cells with centromeres to form transgenic plants; genetic engineering
12/06/2005US6972186 Nucleic acid encoding pro 1410 polypeptides
12/06/2005US6972185 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/06/2005US6972172 Combinatorial complex carbohydrate library for use the detection and screening of drugs
12/06/2005US6972171 mixing polynucleotides with folic acid, hormones, peptides, glycoproteins, lipids or phosphatides to form nucleotides used as drugs; genetic engineering; gene expression
12/06/2005US6972127 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease
12/01/2005WO2005113826A1 Genotyping of multiple loci with pcr for different loci amplification at different temperatures
12/01/2005WO2005113823A2 Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
12/01/2005WO2005113779A2 Plant myo-inositol kinase polynucleotides and methods of use
12/01/2005WO2005113773A1 Polynucleotides for the detection of escherichia coli 0157:h7 and escherichia coli 0157:nm verotoxin producers
12/01/2005WO2005113599A1 C1q family member proteins with altered immunogenicity
12/01/2005WO2005113592A2 Interferon-alpha polypeptides and conjugates
12/01/2005WO2005113573A2 Method of support-based chemical synthesis
12/01/2005WO2005113572A2 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof
12/01/2005WO2005113571A2 Methods for the delivery of oligomeric compounds
12/01/2005WO2005113570A1 Pharmaceuticals for enhanced deliver to disease targets
12/01/2005WO2005113017A2 Gfap-based gene therapy for treatment of retinal diseases
12/01/2005WO2005113016A2 Modulation of glucose-6-phosphatase translocase expression
12/01/2005WO2005112979A2 Methods of preventing and treating alimentary mucositis
12/01/2005WO2005112628A2 Sptrx-3 polypeptide and nucleic acid. uses thereof in methods and compositions for evaluation of male fertility
12/01/2005WO2005097832A3 Humanized anti-tgf-beta antibodies
12/01/2005WO2005082930A3 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
12/01/2005WO2005070967A3 Anti-cancer antibodies with reduced complement fixation
12/01/2005WO2005067643A8 Determination of hepatitis c virus genotype